Literature DB >> 11170039

Preparation of prednisolone-appended alpha-, beta- and gamma-cyclodextrins: substitution at secondary hydroxyl groups and in vitro hydrolysis behavior.

H Yano1, F Hirayama, H Arima, K Uekama.   

Abstract

The carboxyl group of prednisolone 21-hemisuccinate was conjugated to one of the hydroxyl groups of alpha-, beta-, and gamma-cyclodextrins using a coupling agent, carbonyldiimidazole. The direct coupling produced prednisolone-appended cyclodextrin conjugates in which the drug is selectively introduced at one of the secondary hydroxyl groups of cyclodextrins through an ester linkage. The aqueous solubility (> 50% w/v at 25 degrees C) of these conjugates was much higher than those of prednisolone and its 21-hemisuccinate. Prednisolone was slowly released from the conjugate: the percents of prednisolone and its hemisuccinates released from the alpha-, beta-, and gamma-cyclodextrin conjugates were 49, 57, and 85%, respectively, for 24-h. The release pathway is proposed to be via two fast acyl migrations between the 2- and 3-hydroxyl groups of cyclodextrins and between the 21- and 17-hydroxyl groups of prednisolone. The slow release of prednisolone from the ester conjugates was in sharp contrast to the fast release of the prednisolone amide conjugate reported previously. Because of relatively slow and/or site-specific release properties, the present prednisolone-appended cyclodextrin conjugates may be of value as an orally administered delayed-release and/or colon-specific prodrug. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 90:493-503, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170039     DOI: 10.1002/1520-6017(200104)90:4<493::aid-jps1007>3.0.co;2-w

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.

Authors:  Yi-Nuo Pang; Yan Zhang; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

2.  Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.

Authors:  Inho Kim; Hyesik Kong; Younghyun Lee; Sungchae Hong; Jungoh Han; Sunhwa Jung; Yunjin Jung; Young Mi Kim
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

3.  Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.

Authors:  Dawn M George; Raymond J Huntley; Kevin Cusack; David B Duignan; Michael Hoemann; Jacqueline Loud; Regina Mario; Terry Melim; Kelly Mullen; Gagandeep Somal; Lu Wang; Jeremy J Edmunds
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.